Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells

Bone

Volumn 50, Issue 5, 2012, Pages 1092-1099

  Yukita, Akira ^a   Hosoya, Akihiro ^a   Ito, Yuzuru ^b   Katagiri, Takenobu ^c   Asashima, Makoto ^b   Nakamura, Hiroaki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

BMP; C2C12 cells; Differentiation; Osteoblast; SUMO; Ubc9

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PROTEIN UBC9; SMAD4 PROTEIN; SMALL INTERFERING RNA; SUMO PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; MALE; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; REPORTER GENE; SIGNAL TRANSDUCTION; STROMA CELL; SUMOYLATION; TIBIA; WILD TYPE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TIBIA; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN-CONJUGATING ENZYMES; UP-REGULATION;

EID: 84857940642     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.02.008     Document Type: Article

References (35)

1. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
2. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
3. Bragdon B., Moseychuk O., Saldanha S., King D., Julian J., Nohe A. Bone morphogenetic proteins: a critical review. Cell Signal 2011, 23:609-620.
4. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005, 16:251-263.
5. Katagiri T., Imada M., Yanai T., Suda T., Takahashi N., Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes to cells: devoted to molecular & cellular mechanisms 2002, 7:949-960.
6. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006, 99:1233-1239.
7. Yeh E.T., Gong L., Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene 2000, 248:1-14.
8. Muller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2001, 2:202-210.
9. Gong L., Li B., Millas S., Yeh E.T. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett 1999, 448:185-189.
10. Johnson E.S., Schwienhorst I., Dohmen R.J., Blobel G. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J 1997, 16:5509-5519.
11. Desterro J.M., Thomson J., Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett 1997, 417:297-300.
12. Gong L., Kamitani T., Fujise K., Caskey L.S., Yeh E.T. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem 1997, 272:28198-28201.
13. Johnson E.S., Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem 1997, 272:26799-26802.
14. Schwarz S.E., Matuschewski K., Liakopoulos D., Scheffner M., Jentsch S. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc Natl Acad Sci U S A 1998, 95:560-564.
15. Long J., Wang G., He D., Liu F. Repression of Smad4 transcriptional activity by SUMO modification. Biochem J 2004, 379:23-29.
16. Chang C.C., Lin D.Y., Fang H.I., Chen R.H., Shih H.M. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. J Biol Chem 2005, 280:10164-10173.
17. Lin X., Liang M., Liang Y.Y., Brunicardi F.C., Melchior F., Feng X.H. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem 2003, 278:18714-18719.
18. Ohshima T., Shimotohno K. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J Biol Chem 2003, 278:50833-50842.
19. Liang M., Melchior F., Feng X.H., Lin X. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1. J Biol Chem 2004, 279:22857-22865.
20. Shimada K., Suzuki N., Ono Y., Tanaka K., Maeno M., Ito K. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells. Bone 2008, 42:886-893.
21. Miles W.O., Jaffray E., Campbell S.G., Takeda S., Bayston L.J., Basu S.P., et al. Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo. Genes Dev 2008, 22:2578-2590.
22. Kadoya T., Yamamoto H., Suzuki T., Yukita A., Fukui A., Michiue T., et al. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin. Mol Cell Biol 2002, 22:3803-3819.
23. Nakamura H., Yukita A., Ninomiya T., Hosoya A., Hiraga T., Ozawa H. Localization of Thy-1-positive cells in the perichondrium during endochondral ossification. J Histochem Cytochem Official J Histochem Soc 2010, 58:455-462.
24. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
25. Korchynskyi O., Dechering K.J., Sijbers A.M., Olijve W., ten Dijke P. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. J Bone Miner Res Official J Am Soc Bone Miner Res 2003, 18:1177-1185.
26. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998, 95:3597-3602.
27. Wendel M., Sommarin Y., Heinegard D. Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine bone. J Cell Biol 1998, 141:839-847.
28. Choi Y.A., Lim J., Kim K.M., Acharya B., Cho J.Y., Bae Y.C., et al. Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J Proteome Res 2010, 9:2946-2956.
29. Lee P.S., Chang C., Liu D., Derynck R. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J Biol Chem 2003, 278:27853-27863.
30. Xiao Z., Latek R., Lodish H.F. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Oncogene 2003, 22:1057-1069.
31. Seufert W., Futcher B., Jentsch S. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 1995, 373:78-81.
32. Nacerddine K., Lehembre F., Bhaumik M., Artus J., Cohen-Tannoudji M., Babinet C., et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell 2005, 9:769-779.
33. Riquelme C., Barthel K.K., Qin X.F., Liu X. Ubc9 expression is essential for myotube formation in C2C12. Exp Cell Res 2006, 312:2132-2141.
34. Yang S.H., Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol Cell 2004, 13:611-617.
35. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998, 17:3091-3100.